Dr. Ryan Fiorini: Blinktbi

November 14, 2017:  Dr. Fiorini received his Ph.D. in Immunology and Microbiology from the MUSC in Charleston in 2005. He later received his M.B.A. from the Citadel in 2007 and a Masters of Hospital Administration from MUSC in 2008.  Dr. Fiorini has held adjunct faculty positions at both Trident Technical College and the College of Charleston Department of Biology. He previously served as the Vice President of the Palmetto Biotechnology Alliance Board of Directors from 2007-2009 and was designated by the Charleston Business Journal as one of the “Forty Under Forty” in 2010 in recognition of professional success and community involvement. In August 2014, Dr. Fiorini was accepted into the Society of International Business Fellows (SIBF). He served on the Board of Directors for SIBF and the Executive Leadership Board of Directors for the American Heart Association in South Carolina. Since 2014, Fiorini has mentored 20+ companies with the Harbor Entrepreneur Center in Charleston, SC.

In 2009, Dr. Fiorini founded Immunologix, Inc., a bioresearch company. From the company’s commencement in September 2009 through its acquisition by Intrexon Corporation (NYSE: XON) in October 2011, he served as the Founder and Chief Operating Officer. Dr. Fiorini left Intrexon in April 2013 to spend more time looking for “the next” start-up opportunity, building his biotech consulting company and spending time with his growing family. 

In 2014, Dr. Fiorini found “the next” technology he had been looking for and started Perle Bioscience, Inc as the President & CEO. Perle focused on research to treat diabetes. In February 2016, Dr. Fiorini stepped down from the role as CEO.  

In June 2017, Dr. Fiorini co-founded Blinktbi. The Blink technology was licensed from the Zucker Institute of Applied Neuroscience (ZIAN) at MUSC and the company retains exclusive rights to all markets. Blinktbi appears to accurately diagnosis concussion. The device can objectively diagnose a concussion in 20 seconds. The device in currently being tested across 8 sites, including professional, college and high school sports settings, and male and female athletes.  Additionally, the device is being resigned to a very small and efficient hand-held device.  Dr. Fiorini anticipates the machine being ready for sale in April of 2018.  Our President David Burt participated in a test, and was found not to have signs of concussion!   

Thank you Dr. Fiorini for advancing medical science, and sharing your wisdom and vision with our club!  Ryan Fiorini, bus: 843-507-8995;  His email is:  ryan@blinktbi.com

Lisa Van Bergen, Keyway Committee